PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway

Please use this identifier to cite or link to this item: http://ir.sinica.edu.tw/handle/201000000A/83499

Title:	PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway
Authors:	Pai, S Yadav, VK Kuo, KT Pikatan, NW Lin, CS Chien, MH Lee, WH Hsiao, M Chiu, SC Yeh, CT Tsai, JT
Issue Date:	2021-10
Relation:	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22(21), 11492
URI:	http://ir.sinica.edu.tw/handle/201000000A/83499
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1422-0067&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	http://dx.doi.org/10.3390/ijms222111492
Appears in Collections:	基因體研究中心

Show full item record

Check